Trial NCT03955471

View at ClinicalTrials.gov 
Org. Study IDs: 213353
Secondary IDs: 3000-02-006

Last trial update was posted on 2022-09-10

MeSH Interventions

Dostarlimab Niraparib

MeSH Conditions

Carcinoma, Ovarian Epithelial Ovarian Neoplasms

Other Conditions


Stopping Reasons

The study will not resume based on the results of a planned interim analysis that showed futility

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID